CareDx to acquire oncology diagnostics company Naveris for up to $260 million
BRISBANE: CareDx Inc. has agreed to acquire precision oncology diagnostics company Naveris for up to $260 million, expanding its testing services beyond transplant medicine into cancer monitoring. The deal includes $160 million in upfront cash and up to $100 million tied to revenue milestones, the companies said. The transaction is expected to close in the…